In a preclinical model, CCL2-CCR2 was identified as being crucial in the development of atherosclerosis such that the selective deletion of CCR2 significantly decreased atherosclerotic lesions and was associated with a reduced accumulation of monocytes/macrophages. The gene discussed is CCL2; the disease is atherosclerosis.